XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Tables)
9 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of option activity
          
       Weighted- 
       Average 
   Number of   Exercise Price 
   Shares   per Share 
   (In thousands)     
Balance of options outstanding at June 30, 2023   1,325   $3.65 
Expired   (550)   3.84 
Exercised   (152)   1.76 
Balance of options outstanding at March 31, 2024   623   $3.95 
Schedule of RSU activity
          
       Weighted- 
       Average 
       Grant Date 
   Number of   Fair Value 
   Shares   per Share 
   (In thousands)     
Balance of RSUs outstanding at June 30, 2023   1,189   $5.70 
Granted   1,317    4.68 
Forfeited   (99)   5.20 
Vested   (519)   5.59 
Balance of RSUs outstanding at March 31, 2024   1,888   $5.05 
Schedule of PSU activity
     
  

Number of

Shares

 
   (In thousands) 
Balance of PSUs outstanding at June 30, 2023   931 
Granted   1,191 
Forfeited   (346)
Vested   (173)
Balance of PSUs outstanding at March 31, 2024   1,603 
Schedule of employee stock purchase plan
     
   Number of 
   Shares 
   (In thousands) 
Shares available for issuance at June 30, 2023   381 
Shares issued   (92)
Shares available for issuance at March 31, 2024   289 
Schedule of share-based compensation expense
                    
   Three Months Ended   Nine Months Ended 
   March 31,   March 31, 
   2024   2023   2024   2023 
   (In thousands) 
Cost of revenue  $66   $47   $171   $159 
Selling, general and administrative   1,337    1,293    4,238    4,132 
Research and development   469    388    1,381    1,090 
Total share-based compensation expense  $1,872   $1,728   $5,790   $5,381 
Schedule of unrecognized share-based compensation expense
          
   Remaining   Remaining 
   Unrecognized   Weighted- 
   Compensation   Average Years 
   Expense   To Recognize 
   (In thousands)     
Stock options  $251    2.3 
RSUs   8,250    2.1 
PSUs   4,592    2.3 
Stock purchase rights under ESPP   42    0.1 
   $13,135